Document is current
Any future updates will be listed below
-
Authors
Lew, Daniel
Afghani, Elham
Pandol, Stephen
-
Funding
Funding for this research was provided by:
National Institutes of Health (NIH P01 CA163200)
National Institutes of Health (P50 AA11999)
National Institutes of Health (P01 DK098108)
National Institutes of Health (U01 DK108314)
National Institutes of Health (DCP NWU2014-04-01)
U.S. Department of Defense (PR140717P2)
- License Information
-
More Information
Article History
Received: 16 December 2016
Accepted: 2 May 2017
First Online: 13 May 2017
Compliance with ethical standards
:
: This work was supported by the following US federal grants: CA163200, AA11999, DK098108, DoD PR140717P2, DK108314, DCP NWU2014-04-01, W81XWH-16-PRMRP-DA. Dr. Pandol is a founder of Avenzoar Pharmaceuticals and a consultant for Allergan and SunBiopharma. There is no information in this work representing a commercial conflict of interest. Dr. Lew and Dr. Afghani do not have any conflict of interests.
